Physician profile
Melissa Thomas
NPI 1417296039
$1,507.70
in general payments reported to CMS, 2019-2025
20 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $390 · 2023: $112 · 2024: $336 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $296.05 | 2021-2025 | Erleada |
| Novartis Pharmaceuticals Corporation | $177.55 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $176.28 | 2022-2023 | Farxiga |
| Endo USA, INC. | $131.83 | 2024-2025 | Xiaflex, Aveed, Edex |
| Sumitomo Pharma America, INC. | $113.94 | 2024-2025 | Gemtesa, Orgovyx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $106.27 | 2022-2024 | Lifevest |
| Antares Pharma, INC. | $93.58 | 2021-2025 | Xyosted |
| Endo Pharmaceuticals INC. | $52.70 | 2021-2024 | Aveed, Edex, Xiaflex |
| 180 Medical, INC. | $48.23 | 2024-2025 | Gentlecath Glide |
| Merck Sharp & Dohme LLC | $46.24 | 2021-2025 | Keytruda |
| Abbvie INC. | $45.26 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $42.74 | 2025 | Prolaris |
| Pfizer INC. | $42.66 | 2025 | |
| Olympus America INC. | $39.06 | 2025 | Itind System |
| Astellas Pharma US INC | $17.82 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $17.79 | 2024 | Axonics |
| Abc Home Medical Supply, INC. | $17.17 | 2025 | |
| Myovant Sciences INC. | $15.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.44 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.